Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01
January 23, 2025 06:00 ET
|
Greenwich LifeSciences, Inc.
STAFFORD, Texas, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,...
Clinical Trials Support Services Market Poised for Notable Expansion by 2030, Driven by Substantial Investments in R&D from Pharmaceutical and Biopharmaceutical Companies
January 14, 2025 10:55 ET
|
Research and Markets
Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The "Clinical Trials Support Services Market Size, Share & Trends Analysis Report By Phases, By Service, By Sponsor, By Region, And Segment Forecasts,...
AI in Clinical Trials Market Research 2024-2030 with In-depth Assessment of Market Shares, Growth Strategies, and Service Offerings of Leading Players
January 06, 2025 10:13 ET
|
Research and Markets
Dublin, Jan. 06, 2025 (GLOBE NEWSWIRE) -- The "AI in Clinical Trials Market by Function, Phase, Indication, Tool, End-User & Region - Global Forecast to 2030" report has been added to ...
Clinical Trials Outsourcing Market Report 2024: A $70 Billion Industry by 2029, Fueled by Rising Specialized CROs, and Attention Towards Expansion of Functional Service Provider Model
December 31, 2024 06:49 ET
|
Research and Markets
Dublin, Dec. 31, 2024 (GLOBE NEWSWIRE) -- The "Clinical Trials Outsourcing Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The Clinical Trials...
CD40 Targeted Therapies Clinical Trials & Market Opportunity Report 2025, Insight By Company, Country, Indication & Phase
December 09, 2024 04:48 ET
|
Research and Markets
Dublin, Dec. 09, 2024 (GLOBE NEWSWIRE) -- The "CD40 Targeted Therapies Clinical Trials, Therapeutic Approaches & Market Opportunity Insight 2025" report has been added to ...
Clinical Trial Supplies Industry Forecast Report 2025-2033: $4.79 Billion Market Soars as Chronic Disease Incidence Rises Globally
December 05, 2024 04:31 ET
|
Research and Markets
Dublin, Dec. 05, 2024 (GLOBE NEWSWIRE) -- The "Clinical Trial Supplies Market Global Forecast Report by Services, Phase, Therapeutic Area, End Use, Countries and Company Analysis 2025-2033" report...
Greenwich LifeSciences Partners with GIM in Italy
November 26, 2024 06:00 ET
|
Greenwich LifeSciences, Inc.
STAFFORD, Texas, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,...
Brazil Cancer Drugs Market Clinical Trials Report 2024: Brazil Emerges as a Leading Force in Cancer Drug Clinical Trials
August 12, 2024 04:44 ET
|
Research and Markets
Dublin, Aug. 12, 2024 (GLOBE NEWSWIRE) -- The "Brazil Cancer Drugs Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering. With Brazil making significant strides...
Greenwich LifeSciences Announces $2.5 Million Private Placement
June 14, 2024 06:00 ET
|
Greenwich LifeSciences, Inc.
STAFFORD, Texas, June 14, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company" or "Greenwich"), a clinical-stage biopharmaceutical company focused on its Phase III...
Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025
March 13, 2024 06:00 ET
|
Greenwich LifeSciences, Inc.
STAFFORD, Texas, March 13, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,...